Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rhodium(III) Catalyzed C H Activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106831765A reveals Rhodium-catalyzed cyanation for high-purity imidazopyridine intermediates. Achieve cost reduction in pharmaceutical intermediate manufacturing with scalable methods.
Patent CN111217737B details a novel Rhodium-catalyzed tandem reaction for synthesizing bioactive indane scaffolds, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN115925692A details a robust Rh(III)-catalyzed route for trifluoromethyl enamines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN117417339A details Rhodium catalyzed synthesis offering high purity and scalable production for global pharmaceutical intermediate supply chains.
Novel Rh-catalyzed one-pot synthesis of indolo[2,1-a]isoquinolines using sulfur ylides. Efficient route for pharmaceutical intermediates with mild conditions.